Close
Smartlab Europe
Achema middle east

News

Research Brings Hope To Neurodegenerative Disease Sufferers

The development of a neurodegenerative disease in mice is slowed down by a novel therapy, according to researchers. The ground-breaking study may provide hope for treating conditions like Alzheimer's Disease (AD), which is regarded as incurable. Researchers at the University of...

NHS Should Not Employ 5 COVID Therapies, According To NICE

Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications may be used in the National Health Service (NHS), citing cost-effectiveness issues. As the pandemic moves...

IGBA- 2022 WHO Biosimilar Roadmap Facilitates Accessibility

According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association (IGBA), the framework provides a fantastic opportunity to re-evaluate how regulatory standards can better progress...

Abu Dhabi Airports Joins Pharma.Aero As Strategic Member

As a strategic member representing the Middle East, Abu Dhabi Airports has joined Pharma.Aero, a global member network for life science and medical technology manufacturers, certified cargo communities, and airport operators. The partnership with Pharma.Aero builds on Abu Dhabi's development...

GHIT Fund Invests ¥790M On Neglected Tropical Disease Items

Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology (GHIT) Fund in Japan. The parasitic worms that cause lymphatic filariasis, also known as elephantiasis, and...

A New Initiative To Assess Clinical Trials Carbon Footprint

The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to determine the carbon footprint of centralised and decentralised clinical trials, has been launched by The Pistoia Alliance, a non-profit organisation that promotes R&D collaboration...

Seven Pharma CEOs Team Together To Accomplish Emission Aims

Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have launched a collaborative effort to meet short-term emission reduction goals and hasten the implementation of net zero health systems. The Sustainable Markets Initiative (SMI) Health...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »